Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare the clinical performance of the Ultrashape system with VelaShape II device for reduction of the waist.

Clinical Trial Description

UltraShape® Contour I V3 system is a non-invasive (not breaking the skin) focused ultrasound for body contouring purposesdesigned to selectively disrupt sub-dermal fat cells employing focused ultrasound. All other types of tissue, such as blood vessels, muscles and peripheral nerves, remain intact. There are no thermal effects. Fat-cell destruction is achieved by ultrasound-induced mechanical effects during a very short exposure time.

VelaShape is a non-invasive device for Body Reshaping and Cellulite Treatment. VelaShape combines controlled infrared (IR) light and conducted bipolar radiofrequency (RF) energies with mechanical manipulation. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

NCT number NCT02154113
Study type Interventional
Source Syneron Medical
Status Completed
Phase N/A
Start date October 2012
Completion date September 2013

See also
  Status Clinical Trial Phase
Completed NCT02143960 - VelaShape III Device in Comparison to Cryolipolysis for Circumferential Reduction N/A
Active, not recruiting NCT01976247 - A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction N/A
Completed NCT01239147 - Effects of Whole Grain on Weight Maintenance Phase 3
Completed NCT02873104 - Pivotal Study of the truSculpt Radiofrequency Device for Circumferential Reduction N/A
Completed NCT01318343 - Analysis of CoolSculpting by Zeltiq for Non-Invasive Cooling of Abdominal Fat Using the eZ App Large Applicator N/A
Completed NCT03428243 - Long-term Follow-up Study of the truSculpt Radiofrequency Device for Circumferential Reduction